Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Autoimmune Diseases, CNS

Explore clinical trials studying Demyelinating Autoimmune Diseases, CNS. Study availability and eligibility vary by location and protocol.

2,791 public trials 400 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Autoimmune Diseases, CNS trial results

Recruiting

Fatigue Investigation Using Digital Outcomes

NCT07783074

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +31 more
Locations
  • Neurozentrum Basel Messeturm Basel, Switzerland
  • Bellevue Medical Group - Neurozentrum Sternen / Neurozentrum Bellevue Zurich, Canton of Zurich, Switzerland
  • University of Zurich Zurich, Canton of Zurich, Switzerland
  • NeuroPraxis Zürich GmbH Zurich, Canton of Zurich, Switzerland
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 108 locations
View Trial Details
Recruiting

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

NCT07623668

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +13 more
Locations
  • Kahana Oculoplastic and Orbital Surgery Livonia, Michigan, United States
  • Neuro-Eye Clinical Trials Houston, Texas, United States
  • UT Southwestern Medical Center (Ophthalmology CRU) Dallas, Texas, United States
  • Medical University of South Carolina, Storm Eye Institute Charleston, South Carolina, United States
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details

Related conditions